Skip to Main Content

Author Details

Michael A Liss
University of Texas Health San Antonio
2008
202
32
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36097168Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.Prostate Cancer Prostatic Dis2024
37776274Effects of curcumin and ursolic acid in prostate cancer: A systematic review.Urologia2024
36641534Revisiting current National Comprehensive Cancer Network (NCCN) high-risk prostate cancer stratification: a National Cancer Database analysis.Prostate Cancer Prostatic Dis2024
36343223Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.Nutr Cancer2023
37166349Volumetric Analysis of Renal Masses as Predictors of Partial Nephrectomy Outcomes.J Endourol2023
36402643Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis.Clin Genitourin Cancer2023
36842100Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer.Prostate2023
36736700Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy.J Vasc Surg Venous Lymphat Disord2023
34516660Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.Cancer2022
35351370Histological variants of non-muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy.Urol Oncol2022
35351104Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials.BMC Urol2022
35646227The Latinx Disparity in Surgery for Kidney Cancer: Data from The South Texas Region.Kidney Cancer J2022
35343252Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate Cancer.J Urol2022
35467778Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.Cancer Med2022
35830553Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.J Urol2022
35762219A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes.J Urol2022
35572817Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy.Eur Urol Open Sci2022
36461104Predictors of participants' retention-socioeconomic factors or nonadherence: insights from a urological clinical prospective study.Trials2022
36570643Molecular genetic testing does not improve the detection of fluoroquinolone resistance before transrectal prostate biopsy.Prostate Int2022
35935907Diffusion of robot-assisted radical cystectomy: Nationwide trends, predictors, and association with continent urinary diversion.Arab J Urol2022
35864460Accommodating heterogeneous missing data patterns for prostate cancer risk prediction.BMC Med Res Methodol2022
36200522Pilot Study on the Impact of a Home-Based Exercise Program on Inflammatory Cytokines and Quality of Life in Men with Prostate Cancer Under Active Surveillance.Cancer Control2022
35942787Reply by Authors.J Urol2022
35942785Reply by Authors.J Urol2022
35319076Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma.Int J Clin Oncol2022
34980493Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.Eur Urol2022
34854745Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.J Urol2022
35022142Prevalence of pathogenic germline cancer risk variants in testicular cancer patients: Identifying high risk groups.Urol Oncol2022
35260348Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer.Clin Genitourin Cancer2022
34610962GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer.Mol Cancer Res2022
34815548Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial.Prostate Cancer Prostatic Dis2022
32434388Analyzing National Incidences and Predictors of Open Conversion During Minimally Invasive Partial Nephrectomy for cT1 Renal Masses.J Endourol2021
37145399Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort.Urol Pract2021
33763255The association between sarcopenia and bladder cancer-specific mortality and all-cause mortality after radical cystectomy: A systematic review and meta-analysis.Arab J Urol2021
33514567Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression.Cancer Prev Res (Phila)2021
33673346Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer.Int J Mol Sci2021
33644817Transitional Care of Service Members With Genitourinary Injury.Mil Med2021
33617334Restriction Spectrum Imaging-Magnetic Resonance Imaging to Improve Prostate Cancer Imaging in Men on Active Surveillance.J Urol2021
34657653Impact of facility type and volume on survival in patients with metastatic renal cell carcinoma.Can J Urol2021
34045187Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer.Cancer Res2021
34330478Feasibility of dietary folic acid reduction intervention for men on active surveillance for prostate cancer.Clin Nutr ESPEN2021
33403864Editorial Comment.J Urol2021
33423936Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer.Urol Oncol2021
33051659Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.J Clin Endocrinol Metab2021
33446094Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome sampling.BMC Microbiol2021
32343189Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study.J Urol2020
37287182Online Reviews of American Urologists and Opportunities for Improvement.Urol Pract2020
31909204Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signaling.Commun Biol2020
31836465Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.Urology2020
31956078Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only.Urol Oncol2020
  • 1 - 50 of 202

Recommended Authors

Mayo Clinic
Career Start Year 2017
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 4
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 2
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 7
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 13
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 3
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 4
University of Oxford
Career Start Year 2007
Number of shared co-authors 2
University of Alberta
Career Start Year 2007
Number of shared co-authors 4
University of California San Diego
Career Start Year 2005
Number of shared co-authors 5
Winterthur Cantonal Hospital
Career Start Year 2005
Number of shared co-authors 3
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2005
Number of shared co-authors 7
Cambridge University Hospitals NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 2
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 2
David Geffen School of Medicine at university of california los angeles
Career Start Year 2001
Number of shared co-authors 11
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1999
Number of shared co-authors 6
Weill Cornell Medical Center
Career Start Year 1998
Number of shared co-authors 7
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 6
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 11
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 12
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 14
Monash University
Career Start Year 1988
Number of shared co-authors 7
University of Melbourne
Career Start Year 1988
Number of shared co-authors 2
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 2
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 3
University of Oxford
Career Start Year 1987
Number of shared co-authors 13
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 20
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 22

Collaborators

CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 26
university of california san diego School of Medicine
Co-authored papers 25
University of Texas Health San Antonio
Co-authored papers 18
Hunter Medical Research Institute
Co-authored papers 16
university of california san diego School of Medicine
Co-authored papers 12
Co-authored papers 12
University of Michigan ann arbor
Co-authored papers 12
University of British Columbia
Co-authored papers 12
university of california san diego Moores Cancer Center
Co-authored papers 11
Fred Hutchinson Cancer Center
Co-authored papers 10
University of Virginia
Co-authored papers 9
University of Texas Health San Antonio
Co-authored papers 9
University of Texas Health San Antonio (UTHSA)
Co-authored papers 6
University of California San Diego School of Medicine
Co-authored papers 6
National Dong Hwa University
Co-authored papers 6
University of Texas Health San Antonio
Co-authored papers 6
University of California San Diego
Co-authored papers 6
University of California
Co-authored papers 5
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 5
Haukeland University Hospital
Co-authored papers 5
Weill Cornell Medical College
Co-authored papers 5
Co-authored papers 4
Duke University School of Medicine
Co-authored papers 4
Co-authored papers 4
Cedars-Sinai Medical Center
Co-authored papers 4
David Geffen School of Medicine at university of california los angeles
Co-authored papers 3
The University of Texas Health Science Center at San Antonio
Co-authored papers 3
Co-authored papers 3
Eastern Virginia Medical School
Co-authored papers 3
University of Texas Health San Antonio
Co-authored papers 3